GlassScriptPhysician profile
Thomas W Wehmann
NPI 1932280682
$2,754.64
in general payments reported to CMS, 2019-2025
28 companies · $26.48 in 2025
The $26.48 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $1,122 · 2021: $325 · 2022: $326 · 2023: $292 · 2024: $219 · 2025: $26.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430 · Travel and Lodging: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.62 |
| Travel and Lodging | $107.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,197.71 | 2019-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $256.11 | 2019-2025 | Varithena Administration Pack |
| Medtronic, INC. | $246.58 | 2022-2024 | Venaseal |
| Organogenesis INC. | $196.72 | 2021-2023 | Puraply |
| Bard Peripheral Vascular, INC. | $113.60 | 2019-2021 | |
| Silk Road Medical, INC. | $103.22 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lemaitre Vascular, INC. | $95.25 | 2019 | |
| Tei Medical INC. | $62.87 | 2019 | |
| Abbott Laboratories | $58.63 | 2021-2023 | Diamondback Peripheral |
| Integra Lifesciences Corporation | $53.12 | 2020-2022 | |
| Terumo Medical Corporation | $43.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $36.77 | 2022-2023 | Camzyos |
| W. L. Gore & Associates, INC. | $31.72 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Innocoll Pharmaceuticals Limited | $27.57 | 2022 | |
| Medtronic Vascular, INC. | $25.95 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $25.58 | 2023 | Renal - Pd |
| Davol INC. | $19.52 | 2020 | |
| Smith+Nephew, INC. | $17.64 | 2019 | |
| Teleflex LLC | $17.06 | 2023 | Manta |
| Surmodics, INC. | $16.30 | 2023 | Pounce Thrombectomy |
| Argon Medical Devices, INC. | $15.31 | 2021 | |
| Olympus America INC. | $14.95 | 2019 | |
| Cvrx, INC. | $14.63 | 2023 | Barostim Neo System |
| Urgo Medical North America, LLC | $14.47 | 2024 | Urgoclean Ag |
| Inari Medical, INC. | $13.55 | 2021 | |
| Philips North America LLC | $13.46 | 2020 | |
| Cardiva Medical, INC. | $12.89 | 2019 | |
| Medela LLC | $9.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wehmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.